In gastric cancer, c-Myc collaborates with HIF-1α, a key protein in activating AEG (39), to enhance the expression of glycolytic enzymes like Glucose Transporters (GLUT), HK2, PFK, PGK, and LDHA, significantly elevating AEG levels in tumor cells. Here, MYC is linked to gastric cancer.